• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Moradi receives NIH Outstanding Investigator Award

Bioengineer by Bioengineer
September 22, 2022
in Health
Reading Time: 2 mins read
0
Mahmoud Moradi.jpg
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Chemistry professor Mahmoud Moradi, whose research focuses on computational simulations of coronavirus and other diseases, has received an Outstanding Investigator Award from the National Institutes of Health.

Mahmoud Moradi.jpg

Credit: Photo by Sogol Moradi

Chemistry professor Mahmoud Moradi, whose research focuses on computational simulations of coronavirus and other diseases, has received an Outstanding Investigator Award from the National Institutes of Health.

Outstanding Investigator Awards support individual scientists who have demonstrated outstanding research accomplishments and seminal contributions to their field. The awards can be used for any project of the researcher’s choice that fits within the mission of the granting institute.

Moradi, an associate professor of chemistry and biochemistry in the Fulbright College of Arts and Sciences, will receive $1.6 million over five years from the National Institute of General Medical Sciences.

Moradi will use these funds to develop, tailor and fine-tune enhanced sampling and path-finding algorithms to address important biological and biomedical questions. Enhanced sampling and path-finding algorithms are two techniques for the study of molecular dynamics simulation. Both benefit from recent advances in structural biology and supercomputing technology.

The aim of the project is to develop robust sampling and analysis protocols for studying functionally relevant conformational changes of various proteins, from fibroblast growth factor to coronavirus spike protein. The computational models will enable researchers to characterize conformational changes at the molecular level, which could deepen our understanding of diseases and design treatments for them.

Moradi previously received attention for developing computational simulations of the behavior of SARS-CoV-2 spike proteins prior to fusion with human cell receptors. SARS-CoV-2 is the virus that causes COVID-19.



Share12Tweet8Share2ShareShareShare2

Related Posts

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

May 16, 2026

Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma

May 16, 2026

Carboplatin ± Nivolumab in Metastatic TNBC Trial

May 16, 2026

Genetic Dosage Influences Parkinson’s Cognitive Decline

May 16, 2026

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    843 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    730 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma

Carboplatin ± Nivolumab in Metastatic TNBC Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.